Form 4: Fortrea General Counsel Executes Routine Stock Sale Following RSU Vesting

Sentiment:

Insider Transaction Report


Fortrea Holdings Inc.'s General Counsel, James S. Hanson, acquired shares through RSU vesting and subsequently sold a portion to cover tax obligations, a non-discretionary transaction.

Summary

  • James S. Hanson, General Counsel of Fortrea Holdings Inc. (FTRE), reported transactions involving company common stock.
  • On June 2, 2025, Mr. Hanson acquired 7,706 shares of Fortrea Common Stock at a price of $0, resulting from the settlement of Restricted Stock Units (RSUs) on their scheduled vesting date.
  • These RSUs were originally granted by Laboratory Corporation of America Holdings (Labcorp) and converted into Fortrea time-vesting RSUs following the spin-off, vesting on June 1, 2025.
  • Following this acquisition, Mr. Hanson's direct beneficial ownership of Common Stock was 17,172 shares.
  • On June 3, 2025, Mr. Hanson disposed of 2,191 shares of Common Stock at a weighted average price of $4.17 per share, with prices ranging from $3.99 to $4.38.
  • This sale was a 'sell to cover' transaction, mandated by Fortrea's equity incentive plans to satisfy tax withholding obligations related to the RSU vesting, and was not a discretionary trade.
  • After these transactions, Mr. Hanson's direct beneficial ownership of Fortrea Common Stock stands at 14,981 shares.
  • Additionally, Mr. Hanson holds 52,955 Restricted Stock Units (RSUs) following the reported transactions.

Sentiment

Score: 5

Explanation: The sentiment is neutral as the document reports a routine, non-discretionary transaction (RSU vesting and 'sell to cover' for taxes) by an insider, which is a standard part of executive compensation.

Positives

  • The vesting of 7,706 Restricted Stock Units (RSUs) indicates the fulfillment of equity compensation for the General Counsel, reflecting continued tenure and performance.
  • The transaction is a routine 'sell to cover' for tax obligations, which is a standard practice for equity compensation and not indicative of a discretionary sale by the insider.

Negatives

  • The sale of 2,191 shares, even if for tax purposes, reduces the direct common stock holdings of a key executive.

Future Outlook

This Form 4 filing does not contain any forward-looking statements or guidance regarding the company's future financial performance or strategic outlook.

Management Comments

  • The sales reported on this Form 4 represent shares of Common Stock sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of RSUs. These sales are mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a 'sell to cover' transaction and do not represent discretionary trades by the Reporting Person.

Industry Context

This filing is a routine insider transaction report for an executive at Fortrea Holdings Inc., a contract research organization (CRO) that spun off from Labcorp. Such 'sell to cover' transactions are common across all industries when executives receive equity compensation.

Comparison to Industry Standards

  • The 'sell to cover' mechanism for tax withholding is a standard practice in equity compensation plans across various industries, including the pharmaceutical services and CRO sectors. This transaction aligns with typical industry practices for managing RSU vesting and associated tax liabilities.

Related Party Transactions

  • The Restricted Stock Units (RSUs) were originally granted by Laboratory Corporation of America Holdings (Labcorp) and converted into Fortrea time-vesting RSUs pursuant to the terms of the Employee Matters Agreement in connection with the spin-off of Fortrea by Labcorp.

Stakeholder Impact

  • Shareholders: The transaction is a routine insider filing and is unlikely to have a significant direct impact on the share price or shareholder value, as it is a non-discretionary sale for tax purposes.
  • Employees: The RSU vesting and 'sell to cover' mechanism are standard components of executive compensation, reflecting the company's established equity incentive plans.

Key Dates

DateDescription
06/01/2025Vesting date for the Restricted Stock Units (RSUs) that were converted from Labcorp RSUs.
06/02/2025Date of transaction for the settlement of 7,706 RSUs into Fortrea Common Stock.
06/03/2025Date of transaction for the sale of 2,191 shares of Common Stock to cover tax withholding obligations.
06/04/2025Date the Form 4 was signed and filed.

Recommendation

hold

Keywords

Fortrea Holdings Inc., FTRE, SEC Form 4, Insider Trading, Restricted Stock Units, RSU Vesting, Sell to Cover, Equity Compensation, James S. Hanson, General Counsel, Stock Transaction

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.